ZetaGen Therapeutics, is an early stage life science company developing therapeutic solutions for large unmet needs in the regenerative medicine and oncology markets.
We are commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway.
Discovered serendipitously, ZetaGen's products have the potential to transform the treatment of bone-related injuries, procedures and diseases to deliver better outcomes for patients, doctors and payors.